- Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular

All articles

Show search box
A TALEN(T) for treating leukaemia

A TALEN(T) for treating leukaemia

Genome editing with the use of TALENs – the artificial restriction enzymes – was employed for the world first time to cure acute lymphoblastic leukaemia. TALENs helped to modify T cells obtained from a healthy donor in order to beat cancer cells, remaining invisible to immune system and immunosuppres... Read more
Tags genetic engineering , gene therapy , T cells , UCART19 , acute lymphoblastic leukaemia , TALEN , genome editing